Family screening
Think Fabry, think screening at-risk family members.1
Clinical and genetic screening of family members can decrease time to diagnosis for at-risk family members and ensure earlier and more effective disease-specific management of Fabry disease before progression.1,2
Create a detailed family history following the X-linked inheritance pattern to identify at-risk family members2
Adapted from Laney D and Fernoff P. 2008.2
5 additional family members are newly diagnosed (previously undiagnosed) on average through family screening of one Fabry index patient.2
-
Ortiz A, et al. Mol Genet Metab. 2018;123(4):416-427.
-
Laney D and Fernhoff P. J Genet Counsel. 2008;17:79–83.
Gerelateerde paginas
Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).
Bevestig uw status
Bevestig uw status
Sanofi biedt u exclusieve content over onze verschillende therapeutische gebieden op één portal
speciaal voor professionals in de gezondheidszorg, inclusief wetenschappelijk nieuws, een ljst met
evenementen en tools en diensten voor uw dagelijkse praktik.